Sunday, 16 June 2019

Bristol-Myers teams up with Harvard researchers in fibrotic diseases

12 April 2018 | News

Under the terms of the agreement, Harvard academic researchers will collaborate with BMY scientists on four projects over three years.

Singapore - Bristol-Myers Squibb enters into a research collaboration with Harvard Stem Cell Institute's Harvard Fibrosis Network, a group of researchers across the schools and affiliated hospitals of Harvard University, to discover and develop new treatments for fibrotic diseases, including the liver and heart.

Under the terms of the agreement, Harvard academic researchers will collaborate with BMY scientists on four projects over three years.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Podcast

 

Survey Box

Is Asia becoming the centre of healthcare transformation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls